"We have approximately 40 second generation CPPs to test during Q2 before identifying apreferred ‘lead’ candidate/s. The lead candidates will be optimised for drug-like properties andundergo testing in larger animals (both efficacy and toxicity evaluation) before progressing tothe clinic.Phylogica will hold an investor morning to provide shareholders with an update on theevaluation of our second generation CPP candidates in the animal models described above inJune. Further details will be provided closer to the date."
So pretty soon they will have some idea how this is all going. Next announcement sounds like a date to look see. I am not in a position to go, hopefully others are. Identifying the lead candidates will also probably lead to an announcement, and a statement about how good they are.
Fingers crossed. Buy list looks a lot better than a few weeks back. Lets hope it continues.
PYC Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)